Delivery Order SPE2D020D0014-SPE2D025F0634
- Not listed
- This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
- Pfizer Inc. is providing $819,005.63 worth of other medical products to the Defense Logistics Agency Troop Support Medical under an August 15, 2022 firm fixed-price delivery order. No set-aside designation was used for this award. Performance will take place in New York, NY and is required to be completed by August 31, 2023. As the prime contractor, Pfizer will deliver the unspecified medical products directly without involvement of major subcontractors. Pfizer holds additional contracts with...
- This is a $380,405.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract does not have a set-aside designation. Pfizer, a global pharmaceutical company, is providing a variety of pharmaceutical products and supplies to support healthcare initiatives across multiple federal agencies. This contract is part of Pfizer's larger Indefinite Delivery Vehicle (IDV) contracts, including a $7.31 billion Federal Supply...
- The U.S. Department of Defense, through its Medical Supply Chain component, awarded a $2,397.00 firm fixed-price delivery order to Pfizer Inc. on August 20, 2025, for the supply of Quelicin 200 mg/10 ml vials. This single delivery order, which must be completed by August 21, 2025, represents a continuation of Pfizer's established role as a critical supplier of injectable medications and pharmaceutical products to federal healthcare agencies. The contract does not utilize a small business...
- This federal contract award to Pfizer Inc., a global pharmaceutical company, is a delivery order contract with a ceiling value of $1,051.88. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a defense agency, to provide conjugated estrogens injection solution. The contract has a performance period ending on September 19, 2024 and was awarded on September 16, 2024. This contract is not associated with a set-aside program. Pfizer is the prime contractor and does not...
- The Defense Logistics Agency Troop Support Medical awarded a $253,480 delivery order to Pfizer Inc. for conjugated estrogens injection solution. The order was placed against an existing contract vehicle to supply 2 million milliliters of the product. Pfizer will deliver the medication from its New York manufacturing facility to an unspecified customer by August 3, 2023. The firm fixed price order was competitively awarded without any set aside provisions. As a major provider of pharmaceuticals...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Pfizer Inc. on September 25, 2025, for the supply of Premarin 25 mg vials, with a ceiling value of $1,091.08 and a completion date of September 26, 2025. This firm fixed-price delivery order was issued without a small business set-aside designation, reflecting Pfizer's status as a large-scale pharmaceutical manufacturer capable of fulfilling government medical supply requirements. The place of performance is...
- This federal contract award, identified as SPE2D020D0014|SPE2D324F169S, was issued by the Defense Logistics Agency Troop Support Medical (DLA Troop Support) to Pfizer Inc. as the prime contractor. The $2,888.46 firm fixed-price delivery order is for the supply of Penicillin G Benzathine Suspension, a critical antibiotic medication. The contract has an ultimate completion date of August 5, 2024. Pfizer, a large global pharmaceutical corporation, has secured several significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period. The award, valued at $1,092.06, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2D020D0014Indefinite Delivery Contract
- SPE2D020D0014-SPE2D025F0634Delivery Order
Pfizer Inc. has been awarded a delivery order valued at $787,274.80 under the Medical Supply Chain, a Defense Logistics Agency Troop Support program, with a firm fixed price and no small business set-aside. The contract is effective through September 30, 2026, and will be performed in New York, New York. As a leading pharmaceutical supplier to federal government agencies since 2002, Pfizer will deliver critical medical products and supplies to support defense and federal healthcare operations through this ordering mechanism. This delivery order represents part of Pfizer's broader engagement with the federal government's medical supply procurement framework. The company currently holds two significant Indefinite Delivery Vehicle contracts totaling approximately $121 million, including agreements for Rituximab biosimilar products and Bevacizumab injections serving multiple federal healthcare organizations such as the Department of Veterans Affairs, Department of Defense, and Indian Health Service. The current delivery order reinforces Pfizer's strategic role in ensuring the availability of essential pharmaceutical products across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $787.3k | 8/26/25 |